Shan Wang1, Haixia Fan2, Jiankai Xu3, Eryang Zhao4. 1. Department of Oral Pathology, Hospital of Stomatology, The First Affiliated Hospital, Harbin Medical University, Harbin, 150001, People's Republic of China. 2. Department of Anatomy, Basic Medical Science College, Harbin Medical University, Harbin, 150081, People's Republic of China. 3. College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, People's Republic of China. 4. Department of Oral Pathology, Hospital of Stomatology, The First Affiliated Hospital, Harbin Medical University, Harbin, 150001, People's Republic of China. zhaoeryang1956@yeah.net.
Abstract
OBJECTIVE: The objective of this study was to explore the prognostic value of cancer stem cell markers, namely CD133, NANOG, and NOTCH1, in early stage oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: One hundred forty-four patients with early stage (cT1T2N0) OSCC were identified from a pre-existing database of patients with oral cancer. We examined the impact of the immunohistochemical expression of CD133, NANOG, and NOTCH1 in OSCC. Overall survival (OS) curves were calculated using the Kaplan-Meier method. Predictors of outcome were identified using multivariate analysis. RESULTS: We found that CD133, NANOG, and NOTCH1 were significantly associated with lymph node metastasis, and NOTCH1 was also significantly associated with depth of invasion and locoregional recurrence. CONCLUSIONS: NOTCH1 was identified as an independent prognostic factor for OS. CLINICAL RELEVANCE: NOTCH1 might prove to be a useful indicator for high-risk patients with occult metastases from early stage OSCC.
OBJECTIVE: The objective of this study was to explore the prognostic value of cancer stem cell markers, namely CD133, NANOG, and NOTCH1, in early stage oral squamous cell carcinoma (OSCC). MATERIALS AND METHODS: One hundred forty-four patients with early stage (cT1T2N0) OSCC were identified from a pre-existing database of patients with oral cancer. We examined the impact of the immunohistochemical expression of CD133, NANOG, and NOTCH1 in OSCC. Overall survival (OS) curves were calculated using the Kaplan-Meier method. Predictors of outcome were identified using multivariate analysis. RESULTS: We found that CD133, NANOG, and NOTCH1 were significantly associated with lymph node metastasis, and NOTCH1 was also significantly associated with depth of invasion and locoregional recurrence. CONCLUSIONS:NOTCH1 was identified as an independent prognostic factor for OS. CLINICAL RELEVANCE: NOTCH1 might prove to be a useful indicator for high-risk patients with occult metastases from early stage OSCC.
Entities:
Keywords:
CD133; Early stage; NANOG; NOTCH1; Oral squamous cell carcinoma
Authors: Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl Journal: Cancer Res Date: 2006-09-21 Impact factor: 12.701
Authors: Shubham Shrivastava; Robert Steele; Melanie Sowadski; Susan E Crawford; Mark Varvares; Ratna B Ray Journal: Sci Rep Date: 2015-01-15 Impact factor: 4.379
Authors: Bhuvnesh K Sharma; V Manglik; Michael O'Connell; Ashani Weeraratna; Edward C McCarron; Jennifer N Broussard; Kyle A Divito; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal; John L Zapas Journal: Int J Oncol Date: 2012-08-17 Impact factor: 5.650
Authors: Thomas Mücke; David A Mitchell; Stefan Wagenpfeil; Lucas M Ritschl; Klaus-Dietrich Wolff; Anastasios Kanatas Journal: BMC Cancer Date: 2014-05-20 Impact factor: 4.430
Authors: Juan C de Vicente; Tania Rodríguez-Santamarta; Juan P Rodrigo; Eva Allonca; Aitana Vallina; Anusha Singhania; Paula Donate-Pérez Del Molino; Juana M García-Pedrero Journal: J Clin Med Date: 2019-09-03 Impact factor: 4.241
Authors: Alhadi Almangush; Antti A Mäkitie; Laura K Mäkinen; Joonas H Kauppila; Matti Pukkila; Jaana Hagström; Jussi Laranne; Ylermi Soini; Luiz Paulo Kowalski; Reidar Grénman; Caj Haglund; Ricardo D Coletta; Tuula Salo; Ilmo Leivo Journal: Virchows Arch Date: 2018-07-23 Impact factor: 4.064